These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 7869662)

  • 1. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL; Island MD; Massad G
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections.
    Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities.
    Tseng CC; Huang JJ; Ko WC; Yan JJ; Wu JJ
    J Urol; 2001 Nov; 166(5):1643-6. PubMed ID: 11586193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fimbriae of uropathogenic Proteus mirabilis.
    Rocha SP; Pelayo JS; Elias WP
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.
    Burall LS; Harro JM; Li X; Lockatell CV; Himpsl SD; Hebel JR; Johnson DE; Mobley HL
    Infect Immun; 2004 May; 72(5):2922-38. PubMed ID: 15102805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of virulence genes of E. coli strains isolated from children with urinary tract infection.
    Farshad S; Emamghorashi F
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):613-7. PubMed ID: 19587502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are quinolone-resistant uropathogenic Escherichia coli less virulent?
    Vila J; Simon K; Ruiz J; Horcajada JP; Velasco M; Barranco M; Moreno A; Mensa J
    J Infect Dis; 2002 Oct; 186(7):1039-42. PubMed ID: 12232848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of Escherichia coli strains associated with canine urinary tract infections.
    Westerlund B; Pere A; Korhonen TK; Jarvinen AK; Siitonen A; Williams PH
    Res Vet Sci; 1987 May; 42(3):404-6. PubMed ID: 2887017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.
    Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL
    Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of E. coli adhesiveness in the pathogenesis and clinical course of urinary tract infections].
    Krzeska I; Ostojska J; Dzierzanowska D
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):706-9. PubMed ID: 1362812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of virulence factors using DNA probes in uropathogenic strains of Escherichia coli].
    Rodríguez-Alvarez E; Abalia I; Bilbao JR; Umaran A; Cisterna R
    Enferm Infecc Microbiol Clin; 1994 Feb; 12(2):66-70. PubMed ID: 7912109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
    Rocha SP; Elias WP; Cianciarullo AM; Menezes MA; Nara JM; Piazza RM; Silva MR; Moreira CG; Pelayo JS
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract.
    Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL
    Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli).
    Bauer RJ; Zhang L; Foxman B; Siitonen A; Jantunen ME; Saxen H; Marrs CF
    J Infect Dis; 2002 May; 185(10):1521-4. PubMed ID: 11992291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection.
    Tarchouna M; Ferjani A; Ben-Selma W; Boukadida J
    Int J Infect Dis; 2013 Jun; 17(6):e450-3. PubMed ID: 23510539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uropathogenic Escherichia coli--ExPEC pathotype, the best characterized].
    Usein CR; Damian M
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(1):31-6. PubMed ID: 15214194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
    Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
    FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between O serotype and virulent genes in Escherichia coli causing urinary tract infections.
    Emamghoraishi F; Farshad S; Kalani M
    Iran J Kidney Dis; 2011 Jul; 5(4):234-7. PubMed ID: 21725179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between P-fimbriae and resistance to amoxicillin, carbenicillin and tetracycline in uropathogenic strains of Escherichia coli].
    Vranes J; Schönwald S; Zagar Z
    Lijec Vjesn; 1994; 116(7-8):178-81. PubMed ID: 7853994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of bacterial motility by a novel fimbrial gene product.
    Li X; Rasko DA; Lockatell CV; Johnson DE; Mobley HL
    EMBO J; 2001 Sep; 20(17):4854-62. PubMed ID: 11532949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.